As Chief Strategy, Platforms & Transformation Officer for Novartis US, Katie leads an organization that accelerates how strategy is translated into measurable impact by bringing together enterprise strategy, technology platforms, AI-enabled transformation, and operational governance to drive greater speed, alignment, and innovation across the business.
The future of healthcare will be shaped not only by scientific innovation, but by how quickly and effectively organizations can translate bold ideas into meaningful impact for patients. By bringing together strategy, platforms, and transformation capabilities, we have an opportunity to move with greater speed, strengthen collaboration, and build the capabilities needed to deliver lasting value.
Katie joined Novartis US as Vice President, Special Projects, and a member of the US Leadership Team in 2024. In that role, Katie advanced corporate priorities to accelerate Novartis’ ambition to be a top player in the US market, including heading the leadership development and engagement programs for the country’s most senior commercial leaders. In 2025 she assumed the role of Chief Patient Experience Officer, where she led the Novartis Patient Support (NPS) organization, focused on ensuring that anyone prescribed a Novartis therapy can start and stay on treatment.
For nearly 20 years, Katie has built and led global organizations focused on improving the experiences of patients and healthcare professionals. Prior to joining Novartis, Katie held roles in research & development, supply chain, and commercial functions at Johnson & Johnson, and most recently served as Senior Vice President, Patient Engagement and Customer Solutions, where she was responsible for delivering frictionless experiences for patients and healthcare professionals.
Katie is a people-first leader who is passionate about the roles leaders play in creating the environment for innovation and growth. She is a mentor to many talented men and women in healthcare and has been a champion of employee resource groups throughout her career.
Katie earned an MBA from The Wharton School Business at the University of Pennsylvania and a Bachelor of Science degree from Clemson University. A lifelong learner, she has continued to study Artificial Intelligence and Data Science at UC Berkeley Haas School of Business and The Saïd Business School at the University of Oxford.
Outside of Novartis, Katie enjoys outdoor activities and traveling to new places with her family and their labrador, Dolly.
